PyInvesting

Market research

688139.SHG Qingdao Haier Biomedical Co., Ltd

SHG CNY Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
10B
P/E ratio
37.51
Analyst target
37
Dividend yield
1.0%
Beta
0.54

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Qingdao Haier Biomedical Co., Ltd is currently in a long term uptrend where the price is trading 29.9% above its 200 day moving average.

From a valuation standpoint, the stock is 126.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 21.8.

Qingdao Haier Biomedical Co., Ltd's total revenue rose by 48.0% to $421M since the same quarter in the previous year.

Its net income has increased by 122.7% to $109M since the same quarter in the previous year.

Finally, its free cash flow grew by 246.3% to $253M since the same quarter in the previous year.

Based on the above factors, Qingdao Haier Biomedical Co., Ltd gets an overall score of 4/5.